Johanne Louise Brændgaard has a master's degree in international business economics from Aalborg University, Denmark. Johanne Louise Brændgaard has extensive experience in global sales, marketing and project managing within the MedTech industry from positions at Cook Medical and Getinge. Johanne Louise Brændgaard is independent in relation to the company, its management, and its largest shareholders.

A presentation of the current members of the board of directors is available on ADDvise Group's website.

The nomination committee's full proposals to the AGM 2021 will be published in connection with the notice to the AGM 2021.

The nomination committee of ADDvise Group for the AGM 2021 consists of Per-Anders Tammerlöv (chairman of the nomination committee) appointed by Rikard Akhtarzand, shareholder through direct and indirect ownership, Per Åhlgren, shareholder through indirect ownership, Magnus Vahlquist, shareholder through direct and indirect ownership and Staffan Torstensson, chairman of ADDvise Group AB. The members of the nomination committee jointly represent approximately 47 per cent of the votes in the company.  

For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.